CIK 0001824293
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
GRI Bio, Inc.
Sign in to watch- Ticker
- GRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 824369909
- Phone
- +1 619-400-1171
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
- Former names
- Vallon Pharmaceuticals, Inc.
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Director acquired 47,063 shares (other)
- 4 Other acquisition 10% owner acquired 47,063 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at $8.00 ($8,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 4 of 4 · 73 filings